The two biomarkers included in the algorithm are NT-proBNP and urate are nonspecific for CTD-PAH [6]; in this contest, the measurement of sMER, which displayed a good diagnostic accuracy for PAH in SS and SSD patients, could be an additional tool to improve PAH detection algorithms. This evidence concerns the gene NPPB and pulmonary arterial hypertension.